Status:
COMPLETED
[18F] FACBC and [18F] FLT PET Imaging in Central Nervous System Tumors
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Collaborating Sponsors:
Columbia University
Conditions:
Brain Cancer
Gliomas
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to help us understand gliomas, one type of brain tumor. This research protocol makes pictures of gliomas. We will take pictures of the glioma before and after treatment. T...
Eligibility Criteria
Inclusion
- Registered patient at MSKCC.
- Child-bearing age females must be non-pregnant,(documented by a negative pregnancy test within the last 2 weeks), non-lactating, and must be using adequate contraception or be surgically sterile.
- Patients with gliomas
- Patients planning to start anti-AKT and/or anti-VEGF directed therapies .
- Patients with measurable disease on MRI or CT neuroimaging.
Exclusion
- Patient is incontinent of urine or stool (which would make them unable to tolerate lying still for 60 minutes).
- Patient cannot tolerate lying still for a 60 minute session in the PET tomograph.
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 21 2017
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT00832598
Start Date
January 1 2009
End Date
March 21 2017
Last Update
April 27 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Sloan-Kettering Cancer Center
New York, New York, United States, 10065